Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Kyung Cho

Showing results (171-180 of 181) with videos related to

Pageof 19
Sort By:
Gut and Liver|July 28, 2017
Patients' Preferences for Primary Colorectal Cancer Screening: A Survey of the National Colorectal Cancer Screening Program in KoreaYoung-Hak Cho, Dae Ho Kim, Jae Myung Cha, et al.
Journal of Korean Medical Science|May 23, 2014
The clinical characteristics of colonic pseudo-obstruction and the factors associated with medical treatment response: a study based on a multicenter database in KoreaKwang Jae Lee, Kee Wook Jung, Seung-Jae Myung, et al.
Journal of Neurogastroenterology and Motility|July 2, 2020
The Practice of Gastrointestinal Motility Laboratory During COVID-19 Pandemic: Position Statements of the Asian Neurogastroenterology and Motility Association (ANMA-GML-COVID-19 Position Statements)Kewin T H Siah, M Masudur Rahman, Andrew M L Ong, et al.
Neurogastroenterology and Motility|November 26, 2024
Comparison of Tegoprazan and Lansoprazole in Patients With Erosive Esophagitis up to 4 Weeks: A Multi-Center, Randomized, Double-Blind, Active-Comparator Phase 4 TrialCheol Min Shin, Suck Chei Choi, Jin Woong Cho, et al.
Journal of Neurogastroenterology and Motility|October 10, 2023
On-demand Versus Continuous Maintenance Treatment With a Proton Pump Inhibitor for Mild Gastroesophageal Reflux Disease: A Prospective Randomized Multicenter StudyDa Hyun Jung, Young Hoon Youn, Hye-Kyung Jung, et al.
Alimentary Pharmacology & Therapeutics|July 24, 2020
Randomised clinical trial: tegoprazan, a novel potassium-competitive acid blocker, or lansoprazole in the treatment of gastric ulcerYu Kyung Cho, Myung-Gyu Choi, Suck Chei Choi, et al.
Alimentary Pharmacology & Therapeutics|October 31, 2022
Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitisYu Kyung Cho, Jae Hak Kim, Hyun-Soo Kim, et al.
Journal of Neurogastroenterology and Motility|April 3, 2020
2019 Seoul Consensus on Esophageal Achalasia GuidelinesHye-Kyung Jung, Su Jin Hong, Oh Young Lee, et al.
Gut and Liver|June 22, 2026
A Phase III, Randomized, Double-Blind, Active-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Tegoprazan for the Prevention of Peptic Ulcer in Patients on Continuous Long-Term Treatment with Nonsteroidal Anti-Inflammatory DrugsSang Gyun Kim, Tae-Oh Kim, Sung Woo Jung, et al.
Yonsei Medical Journal|September 6, 2016
Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter StudyChang Hwan Choi, In Do Song, Young Ho Kim, et al.
Pageof 19

Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
Gut and Liver|July 28, 2017
Patients' Preferences for Primary Colorectal Cancer Screening: A Survey of the National Colorectal Cancer Screening Program in KoreaYoung-Hak Cho, Dae Ho Kim, Jae Myung Cha, et al.
Journal of Korean Medical Science|May 23, 2014
The clinical characteristics of colonic pseudo-obstruction and the factors associated with medical treatment response: a study based on a multicenter database in KoreaKwang Jae Lee, Kee Wook Jung, Seung-Jae Myung, et al.
Journal of Neurogastroenterology and Motility|July 2, 2020
The Practice of Gastrointestinal Motility Laboratory During COVID-19 Pandemic: Position Statements of the Asian Neurogastroenterology and Motility Association (ANMA-GML-COVID-19 Position Statements)Kewin T H Siah, M Masudur Rahman, Andrew M L Ong, et al.
Neurogastroenterology and Motility|November 26, 2024
Comparison of Tegoprazan and Lansoprazole in Patients With Erosive Esophagitis up to 4 Weeks: A Multi-Center, Randomized, Double-Blind, Active-Comparator Phase 4 TrialCheol Min Shin, Suck Chei Choi, Jin Woong Cho, et al.
Journal of Neurogastroenterology and Motility|October 10, 2023
On-demand Versus Continuous Maintenance Treatment With a Proton Pump Inhibitor for Mild Gastroesophageal Reflux Disease: A Prospective Randomized Multicenter StudyDa Hyun Jung, Young Hoon Youn, Hye-Kyung Jung, et al.
Alimentary Pharmacology & Therapeutics|July 24, 2020
Randomised clinical trial: tegoprazan, a novel potassium-competitive acid blocker, or lansoprazole in the treatment of gastric ulcerYu Kyung Cho, Myung-Gyu Choi, Suck Chei Choi, et al.
Alimentary Pharmacology & Therapeutics|October 31, 2022
Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitisYu Kyung Cho, Jae Hak Kim, Hyun-Soo Kim, et al.
Journal of Neurogastroenterology and Motility|April 3, 2020
2019 Seoul Consensus on Esophageal Achalasia GuidelinesHye-Kyung Jung, Su Jin Hong, Oh Young Lee, et al.
Gut and Liver|June 22, 2026
A Phase III, Randomized, Double-Blind, Active-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Tegoprazan for the Prevention of Peptic Ulcer in Patients on Continuous Long-Term Treatment with Nonsteroidal Anti-Inflammatory DrugsSang Gyun Kim, Tae-Oh Kim, Sung Woo Jung, et al.
Yonsei Medical Journal|September 6, 2016
Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter StudyChang Hwan Choi, In Do Song, Young Ho Kim, et al.
Pageof 19